A carregar...

Incidence, Clinical Features, and Outcomes of Late-onset Neutropenia from Rituximab for Autoimmune Disease

OBJECTIVE: Late-onset neutropenia (LON) is an underrecognized complication of rituximab. Our objective is to describe its incidence, risk factors, clinical features, management, and recurrence. METHODS: We conducted a single-center retrospective cohort study of 738 adult patients with autoimmune dis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Rheumatol
Main Authors: Zonozi, Reza, Wallace, Zachary S., Laliberte, Karen, Huizenga, Noah R., Rosenthal, Jillian M., Rhee, Eugene P., Cortazar, Frank B., Niles, John L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7902364/
https://ncbi.nlm.nih.gov/pubmed/32892495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41501
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!